Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -0.14%287.01B | 1.27%1.17T | -3.45%292.8B | -2.65%290.57B | 3.63%296.52B | 8.55%287.42B | 10.29%1.15T | 11.85%303.25B | 12.39%298.48B | 10.93%286.15B |
Cost of revenue | -2.08%240.9B | -2.21%985.92B | -8.54%242.71B | -7.74%245.28B | 0.00%251.92B | 9.28%246.01B | 15.62%1.01T | 15.88%265.37B | 19.75%265.85B | 17.22%251.9B |
Gross profit | 11.36%46.11B | 25.62%181.4B | 32.27%50.09B | 38.79%45.29B | 30.27%44.6B | 4.43%41.41B | -16.57%144.4B | -10.03%37.87B | -25.10%32.63B | -20.46%34.24B |
Operating expense | 3.40%41.98B | -4.16%164.13B | 0.41%42.13B | -5.95%40.84B | -6.31%40.56B | -4.66%40.6B | 6.38%171.25B | 3.80%41.96B | 5.23%43.42B | 8.88%43.3B |
Staff costs | 1.70%11.19B | 0.16%45.6B | 11.29%12.17B | -2.63%11.17B | -4.22%11.27B | -3.20%11B | 0.39%45.53B | -0.74%10.94B | 0.42%11.47B | 2.50%11.76B |
Selling and administrative expenses | 2.16%22.36B | -9.44%87.55B | -8.35%21.77B | -13.36%21.84B | -8.81%22.06B | -7.01%21.89B | 11.49%96.68B | 5.15%23.75B | 12.61%25.2B | 15.21%24.19B |
-Selling and marketing expense | 3.87%2.92B | -0.19%11.66B | -2.80%2.95B | -2.50%2.85B | 6.80%3.05B | -2.02%2.82B | 2.47%11.68B | 10.94%3.03B | 1.56%2.92B | -2.06%2.86B |
-General and administrative expense | 1.91%19.44B | -10.72%75.89B | -9.16%18.82B | -14.78%18.99B | -10.90%19.01B | -7.70%19.07B | 12.85%85B | 4.35%20.72B | 14.24%22.28B | 18.00%21.33B |
Other operating expenses | 9.34%8.43B | 6.65%30.97B | 12.67%8.19B | 16.06%7.83B | -1.44%7.24B | 0.40%7.71B | 0.45%29.04B | 6.66%7.27B | -9.54%6.75B | 0.70%7.35B |
Operating profit | 408.35%4.14B | 164.30%17.27B | 294.60%7.96B | 141.32%4.46B | 144.60%4.04B | 127.85%814M | -322.09%-26.86B | -345.50%-4.09B | -566.48%-10.79B | -375.79%-9.06B |
Net non-operating interest income (expenses) | 10.69%-1.95B | -31.97%-9.57B | -41.23%-2.72B | -28.30%-2.4B | -29.25%-2.27B | -28.31%-2.18B | -1.46%-7.25B | -10.56%-1.93B | -5.71%-1.87B | 2.45%-1.75B |
Non-operating interest income | 18.52%160M | 35.66%681M | -48.38%159M | 60.92%140M | 414.58%247M | 128.81%135M | 141.35%502M | 234.78%308M | 970.00%87M | -44.83%48M |
Non-operating interest expense | -8.98%2.11B | 32.21%10.25B | 28.87%2.88B | 29.75%2.54B | 39.51%2.51B | 31.68%2.32B | 5.41%7.75B | 21.81%2.23B | 11.26%1.96B | -4.40%1.8B |
Net investment income | -52.13%1.09B | 16.57%4.32B | 192.08%1.4B | 50.46%-535M | 2,241.82%1.18B | -47.83%2.28B | 27.40%3.71B | -43.79%480M | -671.43%-1.08B | -103.02%-55M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | -70.69%603M | -61.94%5.22B | -52.73%753M | -80.73%1.9B | -71.89%515M | 355.09%2.06B | 106.61%13.72B | 1,174.40%1.59B | 778.75%9.84B | 367.35%1.83B |
Income from associates and other participating interests | 111.39%2.1B | -26.10%5.49B | 80.51%426M | -55.89%973M | 2.95%3.1B | -49.85%992M | -13.74%7.43B | -90.21%236M | 35.25%2.21B | -17.70%3.01B |
Special income (charges) | 40.92%-3.46B | 137.39%11.42B | 204.58%22.68B | -104.37%-374M | 11.79%-5.04B | -96.84%-5.85B | -129.15%-30.56B | -459.02%-21.69B | 90.37%-183M | -174.39%-5.71B |
Less:Restructuring and mergern&acquisition | --3.06B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Less:Other special charges | -93.30%392M | -137.39%-11.42B | -204.58%-22.68B | 545.36%1.18B | -25.92%4.23B | 96.84%5.85B | 157.67%30.56B | 460.18%21.69B | -90.37%183M | 195.85%5.71B |
Other non-operating income (expenses) | 78.75%-327M | -89.16%-2.97B | -138.91%-121M | -4.86%-669M | 15.18%-637M | -214.08%-1.54B | 20.93%-1.57B | 1,536.84%311M | 17.68%-638M | 7.28%-751M |
Income before tax | 164.02%2.2B | 175.42%31.2B | 221.13%30.38B | 233.59%3.35B | 107.15%893M | -165.27%-3.43B | -630.52%-41.37B | -4,477.37%-25.08B | -409.89%-2.51B | -379.22%-12.48B |
Income tax | 265.35%2.4B | -42.85%4.16B | -62.75%-1.8B | 110.33%1.49B | 154.81%3.82B | -89.36%658M | 60.22%7.28B | -678.87%-1.11B | 125.88%707M | -60.96%1.5B |
Net income | 94.94%-207M | 155.57%27.03B | 234.22%32.18B | 157.98%1.86B | 79.08%-2.92B | 45.30%-4.09B | -1,596.37%-48.65B | -5,791.40%-23.98B | -747.78%-3.21B | -2,308.53%-13.98B |
Net income continuous operations | 94.91%-208M | 155.57%27.03B | 234.22%32.18B | 157.93%1.86B | 79.08%-2.92B | 45.32%-4.09B | -1,595.91%-48.65B | -5,805.91%-23.98B | -747.98%-3.21B | -2,308.37%-13.98B |
Noncontrolling interests | -25.21%881M | 143.80%4.29B | 56.67%1.14B | 91.75%790M | 1,267.33%1.18B | 63.61%1.18B | 39.52%1.76B | 7,370.00%727M | 35.53%412M | -132.69%-101M |
Net income attributable to the company | 79.32%-1.09B | 145.13%22.75B | 225.65%31.04B | 129.61%1.07B | 70.44%-4.1B | 35.74%-5.27B | -2,632.96%-50.41B | -6,123.17%-24.71B | -1,997.38%-3.62B | -4,370.46%-13.88B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 79.32%-1.09B | 145.13%22.75B | 225.65%31.04B | 129.61%1.07B | 70.44%-4.1B | 35.74%-5.27B | -2,632.96%-50.41B | -6,123.17%-24.71B | -1,997.38%-3.62B | -4,370.46%-13.88B |
Gross dividend payment | ||||||||||
Basic earnings per share | 79.31%-9.44 | 145.18%197.09 | 225.79%268.98 | 129.62%9.29 | 70.41%-35.55 | 35.69%-45.63 | -2,632.10%-436.28 | -6,116.28%-213.84 | -1,989.16%-31.36 | -4,375.09%-120.13 |
Diluted earnings per share | 79.31%-9.44 | 145.18%197.09 | 225.79%268.98 | 129.62%9.29 | 70.41%-35.55 | 35.69%-45.63 | -2,632.10%-436.28 | -6,116.28%-213.84 | -1,996.91%-31.3675 | -4,375.09%-120.13 |
Dividend per share | 0 | 10 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |